Venus Concept Inc. VERO
Set alert
At close · Apr 6
After hours · Apr 6, 4:00 PM ET
- YTD
- -78.99%
- 1 year
- -86.82%
- Open
- 0.2683
- Prev close
- 0.311
- Mkt cap
- 2.33M
- Vol
- 43
- Avg vol
- 1.25M
- EPS
- -7.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2683
- High
- 0.311
- Forward P/E
- -0.14
- Beta
- 0.64
- Short ratio
- 0.69
- Inst. own
- 27.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 0.37878
- 200-d avg
- 0.58925
- 1y target
- 0.00
Key statistics
- Market cap
- 2.33M
- Enterprise value
- 47.50M
- Trailing P/E
- 0.00
- Forward P/E
- -0.14
- PEG ratio
- 0.00
- Price / sales
- 0.03
- Price / book
- 0.00
- EPS (TTM)
- -7.97
- Beta
- 0.64
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -71.52%
- Revenue (TTM)
- 69.81M
- Revenue growth
- -17.40%
- Free cash flow
- -1.06M
- Total cash
- 5.73M
- Total debt
- 50.03M
- Return on equity
- 0.00%
- Shares outstanding
- 7.26M
- Short % of float
- 28.86%
- 50-day average
- 0.37878
- 200-day average
- 0.58925
Analyst view
Consensus: none
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Aug 13, 2024
Expected Aug 13, 2024. Consensus EPS estimate -0.92.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -1.28 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -1.39 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.68 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -2.01 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 2023 | BTIG | down | Buy | Neutral |
About Venus Concept Inc.
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Canada
- Website
- venus.ai
News
- Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada
- Venus Concept Announces Senior Management Changes
- Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger
- Venus Concept Inc. (NASDAQ:VERO) Sees Significant Drop in Short Interest
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Dow Surges 300 Points; Netflix Shares Fall After Q4 Results
- Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC
Your note
Sign in to keep a note on VERO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DELLA PENNA DOMENIC | Officer | Stock Award(Grant) | Mar 23, 2023 | 151,385 |
| GEORGIADIS ANNA | Officer | Stock Award(Grant) | Mar 23, 2023 | 25,659 |
| MANDARELLO MICHAEL | General Counsel | Stock Award(Grant) | Aug 10, 2023 | 1,491 |
| MASTERS MICHAEL WILLINGHAM | Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 2, 2024 | 0 |
| MCGRAIL WILLIAM H | Officer | Stock Award(Grant) | Mar 23, 2023 | 7,783 |
| NATALE ANTHONY | Director | Sale | Dec 2, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Essex Woodlands Management Inc. | 15.01% | 1,089,190 | 349.08K | Sep 29, 2024 |
| Masters Capital Management, LLC | 8.57% | 621,740 | 199.27K | Sep 29, 2024 |
| Vanguard Group Inc | 0.45% | 32,438 | 10.40K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.40% | 29,055 | 9.31K | Sep 29, 2024 |
| HRT Financial LP | 0.25% | 18,138 | 5.81K | Sep 29, 2024 |
| Firethorn Wealth Partners, LLC | 0.14% | 10,050 | 3.22K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.45% | 32,438 | 10.40K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.32% | 22,944 | 7.35K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.08% | 6,114 | 1.96K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.01% | 1,079 | 345 | Oct 30, 2024 |
| Nuveen Nasdaq 100 Dynamic Overwrite Fund | 0.00% | 1 | 0 | Oct 30, 2024 |